Fludarabine Phosphate 50mg Powder for Solution for Injection or Infusion

Licence status
Withdrawn: 04/10/2022
Active substances
Fludarabine phosphate
Dosage Form
Powder for solution for injection/infusion
Licence number
PA1422/013/001
Licence holder
Fresenius Kabi Oncology Plc

Product documents

Licence information

ATC code
L01BB Purine analogues, L01BB05 fludarabine
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
03/05/2013